Panel approach to Blood Cancer Molecular Testing With Pre-Plated Bloodhound Molecular Assays.

Precipio’s molecular kits use proprietary mutation detection technology that is rapid, cost-effective, and easy-to-use. Our molecular kits can be run on most RT-PCR instruments to identify gene mutations and other variants at low limits of detection.

This technology enables detection of multiple genes of interest (driver mutations) for these blood cancers on a single platform, in a pre-plated assay configuration to further simplify hematopathology workflows.

These molecular kits have been validated as lab developed tests at Precipio’s clinical hematopathology laboratory. They have not been approved by the FDA.